Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - Wiley Online Library
The principle of nano‐surface and molecular‐orientation limited (nSMOL) proteolysis has a
unique characteristic Fab‐selective proteolysis for antibody bioanalysis that is independent …

[引用][C] Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - cir.nii.ac.jp
Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion
biopharmaceuticals Etanercept and Abatacept in human serum | CiNii Research CiNii 国立 …

[PDF][PDF] Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama, M Takanashi, A Yonezawa… - 2018 - scienceopen.com
The principle of nano‐surface and molecular‐orientation limited (nSMOL) proteolysis has a
unique characteristic Fab‐selective proteolysis for antibody bioanalysis that is independent …

Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - search.proquest.com
The principle of nano‐surface and molecular‐orientation limited (nSMOL) proteolysis has a
unique characteristic Fab‐selective proteolysis for antibody bioanalysis that is independent …

Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - keio.elsevierpure.com
抄録 The principle of nano-surface and molecular-orientation limited (nSMOL) proteolysis
has a unique characteristic Fab-selective proteolysis for antibody bioanalysis that is …

[HTML][HTML] Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - ncbi.nlm.nih.gov
The principle of nano‐surface and molecular‐orientation limited (nSMOL) proteolysis has a
unique characteristic Fab‐selective proteolysis for antibody bioanalysis that is independent …

Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum.

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - europepmc.org
The principle of nano‐surface and molecular‐orientation limited (nSMOL) proteolysis has a
unique characteristic Fab‐selective proteolysis for antibody bioanalysis that is independent …

Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama… - Pharmacology …, 2018 - pubmed.ncbi.nlm.nih.gov
The principle of nano-surface and molecular-orientation limited (nSMOL) proteolysis has a
unique characteristic Fab-selective proteolysis for antibody bioanalysis that is independent …

Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum.

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - europepmc.org
The principle of nano‐surface and molecular‐orientation limited (nSMOL) proteolysis has a
unique characteristic Fab‐selective proteolysis for antibody bioanalysis that is independent …

Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum

N Iwamoto, K Yokoyama, M Takanashi… - Pharmacology …, 2018 - keio.elsevierpure.com
The principle of nano-surface and molecular-orientation limited (nSMOL) proteolysis has a
unique characteristic Fab-selective proteolysis for antibody bioanalysis that is independent …